1. 3D Ex vivo tissue platforms to investigate the early phases of influenza a virus- and SARS-CoV-2-induced respiratory diseases. Issue 1 (31st December 2022) Authors: Schloer, Sebastian; Treuherz, Daniel; Faist, Aileen; de Witt, Marlous; Wunderlich, Katharina; Wiewrodt, Rainer; Wiebe, Karsten; Barth, Peter; Wälzlein, Joo-Hee; Kummer, Susann; Balkema-Buschmann, Anne; Ludwig, Stephan; Brunotte, Linda; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 11:Issue 1(2022) Page Start: 2160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities. Issue 1 (1st January 2019) Authors: Matos, Aline da Rocha; Wunderlich, Katharina; Schloer, Sebastian; Schughart, Klaus; Geffers, Robert; Seders, Martine; Witt, Marlous de; Christersson, Anmari; Wiewrodt, Rainer; Wiebe, Karsten; Barth, Peter; Hocke, Andreas; Hippenstiel, Stefan; Hönzke, Katja; Dittmer, Ulf; Sutter, Kathrin; Rescher,... Journal: Emerging microbes & infections Issue: Volume 8:Issue 1(2019) Page Start: 1763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Drug synergy of combinatory treatment with remdesivir and the repurposed drugs fluoxetine and itraconazole effectively impairs SARS‐CoV‐2 infection in vitro. (6th April 2021) Authors: Schloer, Sebastian; Brunotte, Linda; Mecate‐Zambrano, Angeles; Zheng, Shuyu; Tang, Jing; Ludwig, Stephan; Rescher, Ursula Journal: British journal of pharmacology Issue: Volume 178:Number 11(2021) Page Start: 2339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Issue 6 (1st December 2022) Authors: Hönzke, Katja; Obermayer, Benedikt; Mache, Christin; Fathykova, Diana; Kessler, Mirjana; Dökel, Simon; Wyler, Emanuel; Baumgardt, Morris; Löwa, Anna; Hoffmann, Karen; Graff, Patrick; Schulze, Jessica; Mieth, Maren; Hellwig, Katharina; Demir, Zeynep; Biere, Barbara; Brunotte, Linda; Mecate-Zambran... Journal: European respiratory journal Issue: Volume 60:Issue 6(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Targeting the endolysosomal host-SARS-CoV-2 interface by clinically licensed functional inhibitors of acid sphingomyelinase (FIASMA) including the antidepressant fluoxetine. Issue 1 (1st January 2020) Authors: Schloer, Sebastian; Brunotte, Linda; Goretzko, Jonas; Mecate-Zambrano, Angeles; Korthals, Nadia; Gerke, Volker; Ludwig, Stephan; Rescher, Ursula Journal: Emerging microbes & infections Issue: Volume 9:Issue 1(2020) Page Start: 2245 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗